Publications : Andrew Lautz

Blog 

Why a Contract-Based Solution to Surprise Billing Is Best for Taxpayers and Patients

by Andrew Lautz January 24, 2020

Letters 

NTU Praises New Bills That Would Make Health Care More Personal and Portable

by Andrew Lautz January 21, 2020

Letters 

Coalition of 21 Organizations Urges Significant Changes to Proposed Commerce Rule

by Andrew Lautz January 10, 2020

Blog 

Importing Single Payer Style Price Controls Is Not the Way to Lower U.S. Drug Costs

by Andrew Lautz December 19, 2019

Vote Alert 

Lawmakers Should Oppose the Nearly $1.4-Trillion Budget Deal

by Andrew Lautz December 17, 2019

Op-Ed 

We Hate Surprise Bills. Why Should we Accept one From Congress?

by Andrew Lautz December 13, 2019

Letters 

Congress Should Not Reduce Incentives for Generic Drug Competition

by Andrew Lautz December 12, 2019

Blog 

New Drug Pricing Bill Offers Several Promising Bipartisan Ideas

by Andrew Lautz December 11, 2019

Letters 

Coalition Urges Congress to Avoid Jamming Last-Minute Surprise Billing Deal Into Year-End Legislation

by Andrew Lautz December 11, 2019

Vote Alert 

Representatives Should Vote No on H.R. 3, the Pelosi Drug Pricing Plan

by Andrew Lautz December 10, 2019

Blog 

Generic Drugs Save Taxpayers and Patients Money. Congress Could Accidentally Hurt Them This Month.

by Andrew Lautz December 09, 2019

Letters 

NTU Identifies Pro-Taxpayer Amendments for Pelosi Drug Pricing Bill

by Andrew Lautz December 09, 2019

Blog 

Some Generic Drugs Are Not Making It Onto Part D Formularies. A New Bill Could Fix That.

by Andrew Lautz November 22, 2019

Blog 

NTU Applauds Effort to Codify HRAs Into Law

by Andrew Lautz November 22, 2019